Physician profile
Stuart M Hilliard
NPI 1366651630
$20,970.09
in general payments reported to CMS, 2019-2025
12 companies · $13K in 2025
The $13K reported for 2025 was more than what 94% of Surgery of The Hand (Surgery) providers received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,311 · 2020: $25.89 · 2021: $1,475 · 2022: $1,343 · 2023: $351 · 2024: $3,019 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,400 · Food and Beverage: $4,397 · Travel and Lodging: $4,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,400.00 |
| Food and Beverage | $4,396.84 |
| Travel and Lodging | $4,017.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $13,757.66 | 2022-2025 | Sx-One Microknife |
| Pylant Medical | $2,254.81 | 2019-2024 | |
| Arthrex, INC. | $1,841.30 | 2021-2024 | |
| Trimed, INC. | $1,122.05 | 2025 | |
| Acumed LLC | $996.25 | 2019-2025 | Acumed, Nanophix Implant, Inframe Implant |
| Stryker Corporation | $459.17 | 2023-2025 | Variax, Allofiber, Ignite |
| Integra Lifesciences Corporation | $348.21 | 2019 | |
| Exsomed Corporation | $65.15 | 2019 | |
| Endo Pharmaceuticals INC. | $42.36 | 2019-2023 | Xiaflex |
| Axogen | $41.16 | 2019 | |
| Polynovo North America LLC | $27.40 | 2025 | Novosorb Btm |
| Alafair Biosciences, INC. | $14.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Hilliard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.